Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy
Triple therapy with ursodeoxycholic acid, obeticholic acid, and fibrates leads to normalization of biochemical liver tests and pruritus improvement in patients with difficult‐to‐treat primary biliary cholangitis, as shown in a study.
